
Thu 13 November 2025
Warszawa (PL)
5/0°C
|
Thu
|
Fri
|
Sat
|
Sun
|
| 12 |
11 |
11 |
9 |
Thu 13 November 2025
Praha (CZ)
4/0°C
|
Thu
|
Fri
|
Sat
|
Sun
|
| 11 |
13 |
11 |
8 |
Thu 13 November 2025
Bratislava (SK)
5/0°C
|
Thu
|
Fri
|
Sat
|
Sun
|
| 14 |
14 |
11 |
12 |
Thu 13 November 2025
Budapest (HU)
5/0°C
|
Thu
|
Fri
|
Sat
|
Sun
|
| 14 |
14 |
13 |
13 |



February 16th, 2021
The Czech State Drugs Control Institute (SUKL) recommended an anti-coronavirus drug by the Regeneron company to be used in Czechia even though it has not been registered yet, SUKL director Irena Storova tweeted today. The drug is based on a combination of two monoclonal antibodies, Casirivimab and Imdevimab. It is meant for high-risk outpatients. A week ago, the SUKL recommended the first monoclonal-based drug from the U.S. Eli Lilly firm and its usage was approved by the Health Ministry, too, some days after.
CTK
Pageviews this month:
85,623